TRIM31 and colorectal carcinoma: To support this notion, we have shown that MAVS normally interacting with TRIM31 to facilitate antiviral immune response is downregulated in CRC samples (Supplementary Figure S6) and therefore TRIM31 may not function as it is normally reported in antiviral immune response.